Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Thrombosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Thrombosis
    Low-Molecular-Weight Heparin Reduces Risk of Venous Clots in Patients With Pancreatic Cancer: Presented at ASH - (DGDispatch)
    Once-Daily Enoxaparin Feasible in Some Children at Risk of Venous Thromboembolism: Presented at ASH - (DGDispatch)
    Updated Guidelines for the Management of Antithrombotic Agents for Endoscopic Procedures - (DGNews)
    Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism - (N Engl J Med)
    Extending Rivaroxaban Prophylaxis Significantly Reduces Risk of Venous Thromboembolic Events: Presented at ASH - (DGDispatch)

    News archive

     Recent webcasts/CME - Thrombosis
    • Managing Treatment- and Disease-Related Complications in Multiple Myeloma
    • Thrombosis in Multiple Myeloma: Choice of Thromboprophylaxis Depends on Type of Therapy and Individual Risk of Patient
    • Peripheral Neuropathy in Multiple Myeloma: Early Recognition and Intervention Key to Minimize Long-Term Complications
    • Myeloma Bone Disease: Is Targeting of Osteoclastic and Osteoblastic Mechanisms Necessary for Effective Therapy?
    • Update on DVT and PE in OB Gyn/Ortho Patients

      Webcasts/CME archive

       Recent cases - Thrombosis
        An Unusual Differential Diagnosis Of Suspected Deep Vein Thrombosis
        Fatal Cardiac Tamponade Due To Coronary Sinus Thrombosis In Acute Lymphoblastic Leukemia: A Case Report
        A Latent Form Of Essential Thrombocythemia Presenting As Portal Cavernoma
        Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
        Multiorgan Paradoxical Embolism Consequent to Acute Pulmonary Thromboembolism with Patent Foramen Ovale: A Case Report

        Cases archive
          




        my personal edition > thrombosis > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Postoperative Thrombin Generation in Cardiac Surgery: Presented at ASA

          By Lexa W. Lee

          NEW ORLEANS -- October 19, 2009 -- Thromboembolic prophylaxis after cardiac surgery is important because the capacity for thrombin generation increases postoperatively, as reported in the results of a new study at the 2009 Annual Meeting of the American Society of Anesthesologists (ASA).

          There are only limited data about haemostatic changes that occur after open-heart surgery; most of the literature concerns perioperative bleeding and intraoperative haemostasis. Postoperatively, however, thrombotic events in cardiac surgery patients may be due to systemic thrombin generation, noted lead investigator Susanne Lison MD, Ludwig Maximilians University of Munich, Munich, Germany, presenting her study here on October 17.

          The purpose of this study was to evaluate postoperative thrombin generation by measuring prothrombin fragment 1+2 (F1+2), an indicator of ongoing thrombin generation in plasma. The thrombin dynamics test (TDT) was used to quantify the enzymatic thrombin activity that can potentially be activated in plasma.

          The researchers prospectively enrolled 220 first-time cardiac-surgery patients. Of these, 134 had coronary-artery bypass grafts (CABG) and 86 had aortic-valve replacement (AVR). Standard perioperative procedures were followed. Blood samples were taken preoperatively, at the end of operation, 4 hours after the end of operation, and the morning of postoperative days 1, 3, and 5. TDT, thrombin onset time, and levels of F1+2, fibrinogen, and a fibrin degradation product known as D-dimer were recorded.

          TDT was significantly reduced at the end of operation (83%, P < .05) relative to preoperative values (97%). On postoperative day 1, TDT was significantly elevated (100%, P < .05). Levels returned to near-preoperative values on postoperative day 3 (98%).

          After coumadin treatment in the AVR group, TDT was significantly reduced on postoperative day 3 and 5 (P < .05). In the CABG group (which did not receive coumadin), TDT remained significantly elevated.

          All patients showed a peak of F1+2 immediately at the end of operation (922 pmol/L) relative to preoperatively (160 pmol/L). Levels remained significantly elevated (222 pmol/L, postoperative day 1; 246 pmol/L, postoperative day 3; 256 pmol/L, postoperative day 5, P < .05). Fibrinogen levels were significantly decreased at the end of operation and 4 hours after the end of operation, but increased significantly above preoperative levels on postoperative day 1, and further increased during the 4 remaining days.

          D-dimer showed increased fibrinogen levels at the end of operation and further increased during the remaining days.

          Mortality within 30 days was 1.4%.

          The researchers concluded that there is an elevated thrombin-generating capacity or "procoagulant milieu," accompanied by ongoing thrombin generation (represented by F1+2), which can raise the postoperative risk of thromboembolic complications in patients who have undergone major cardiac surgery.

          The investigators believed the initial drop in TDT values at the end of operation to have been partly independent of cardiopulmonary bypass, and are related instead to surgical stress with systemic inflammation.

          Coumadin treatment in the AVR patients reduced TDT significantly, which might help reduce thrombotic complications postoperatively despite ongoing thrombin generation.

          No association between TDT and adverse events was found. This lack of association was thought to be due to small sample size and the low incidence of complications. Nonetheless, it is the opinion of the researchers that proper attention be given to postoperative thromboembolic prophylaxis in cardiac surgery.

          [Presentation title: Thrombin Generation in the Postoperative Period After Cardiac Surgery. Abstract A49]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send